Childhood Vaccine Program provider agreement renewal continues into April! Renewals are organized by county so please check out the Renewal Schedule. Some agreements will be expiring March 31st. Providers with expired agreements will not be able to place an order until they have an approved 2024 agreement in the IIS. Don't forget to check the comments at the top if your agreement has been returned for edits!
We have resources available to help you with this process:
If you haven't done so yet, ensure your clinic is ready to renew by completing the following:
- Annual You Call the Shots training modules for primary and backup vaccine coordinators
- Gather practice profile data for 2023
- Ensure all thermometer calibrations are up to date
While the onset and duration of RSV season may vary throughout the United States, nirsevimab is typically administered October through the end of March in most of the continental US.
Healthcare providers should stop administering nirsevimab by March 31. As of March 14, 2024, Nirsevimab is no longer available for ordering through the Childhood Vaccine Program.
Remaining inventory of nirsevimab is viable until its expiration date. Product should continue to be safely stored refrigerated between 36°F to 46°F (2°C to 8°C) and can be used when administration resumes next season. More information can be found here: Frequently Asked Questions About RSV Immunization with Monoclonal Antibody for Children 19 Months and Younger | CDC
MassBiologics has discontinued production of their Td vaccine, TdVaxTM. Supply of TdVaxTM is anticipated to last through June. It is anticipated that the supply of Td vaccine in the US market will be constrained through 2024. Sanofi, manufacturer of Tenivac®, is taking steps to augment their available supply of Td for the US and will be implementing ordering controls until the supply has increased.
As a result, CDC put allocations into place, effective 2/23/2024, for all three Td vaccine presentations (Grifols vials; Sanofi vials; and Sanofi syringes). States will receive thresholds across the three presentations. The total threshold across the three presentations will be less than each state’s historical usage of Td vaccine. Thresholds will be refreshed monthly. The total doses available each month are anticipated to remain level while ordering controls are in effect. However, states and providers should anticipate that the mix of products will change over time and will eventually adjust to include only Sanofi products.
Vaccine choice is occurring from Monday April 1st through Friday April 12th. During this time providers can fill out the Vaccine Choice form to request a change in the brand of vaccine they receive for vaccines with more than one brand available.
Please use the following link to access the form to request changes. You only need to submit a form if you are requesting a change. If you are keeping the same vaccines no form is needed.
Vaccine Choice Worksheet (wa.gov)
Submit forms either by e-mail to WAChildhoodVaccines@doh.wa.gov or by fax to 360-236-3811.
If you have any questions please contact Jacki Stockdale at jacki.stockdale@doh.wa.gov
Some vaccine choice highlights:
- It is anticipated that Penbraya will soon be available to order. Due to the Men B component and the inability to interchange the Men B vaccine, Penbraya will be available only to those that receive Trumenba as their Men B product.
- MassBiologics is no longer manufacturing their Td product, TdVax. Once supply of TdVax is exhausted all providers will receive Tenivac. Therefore Td has been removed from the vaccine choice form.
- If a vaccine is not on the Vaccine Choice Worksheet as an option, it indicates that there is only one brand for that vaccine and is automatically on all order sets.
Beginning the week of March 18th, the McKesson Distribution Center temporarily began shipping refrigerated coolers using one of two different cold temperature indicator cards. Coolers may contain the familiar FREEZEmarker indicator card or may contain a new indicator card called TransTracker. Both indicator cards include the same temperature indicator that is currently being used. The only difference is the indicator card itself. Providers will not receive both monitors in the same cooler and should continue to follow the same process for checking for any temperature excursions.
|